Aviso for Pharma and Life Sciences: Scaling Seller-HCP Digital Engagement to Boost Business Value
Apr 8, 2025
The pharmaceutical sales landscape has undergone significant transformation in recent years, a shift accelerated by the global pandemic and its aftermath. COVID-19 dramatically changed the way pharmaceutical companies engage with healthcare professionals (HCPs), establishing digital communication tools such as video calls as essential elements of the new normal. Despite the cautious resumption of in-person meetings, a substantial 59% of HCPs continue to favor digital platforms, indicating a permanent shift in their interaction preferences.
Yet, this rising digital affinity and the proliferation of channels have introduced their own challenges. A concerning 80% of HCPs report a lack of personalized interactions, and 85% of pharma executives acknowledge that their current strategies fall short of true omnichannel engagement. This reality has prompted pharmaceutical companies to reevaluate and transform their existing HCP engagement models.
As the life science industry progresses, the role of AI becomes increasingly central. AI is poised to enhance rep productivity and tailor engagement strategies to meet the sophisticated demands of the new digital landscape in pharmaceutical sales, ensuring that pharmaceutical companies can adapt and thrive in this changing environment.
Aviso’s AI revenue operating system is designed to power digital sales transformation for specialized industries such as Pharma & Life Sciences. Our platform offers unparalleled insights and foresight, empowering your sales and marketing teams to make data-driven decisions with precision and speed.
Integrating AI for Digital Synergy
AI has the potential to significantly transform the pharmaceutical industry by realigning engagement strategies to more effectively meet the expectations of HCPs, thereby enhancing patient outcomes.
Did you know that integrating AI in pharma operations can boost efficiency by up to 70%?
Omni-channel communication and AI-driven strategies are now at the forefront of the Life Sciences and Pharmaceutical industries, pressing companies to deliver a consistent and efficient digital experience for all stakeholders.
A recent report by Accenture noted that 40% of all working hours in the sector will be influenced by generative AI. Despite this significant impact, only half of the organizations surveyed have a comprehensive plan to ensure positive experiences and outcomes. To ensure successful AI adoption, organizations must assess their readiness through strategic planning that includes thorough risk assessments, workforce training, and technology infrastructure evaluation. Developing a roadmap that includes these elements can facilitate smooth integration and optimize AI's potential benefits.
Companies should prioritize scalable cloud solutions that can handle large data volumes and complex processing needs to minimize the challenges of integrating AI. Investing in interoperable systems that integrate with existing technologies and adhering to strict cybersecurity measures are also crucial to safeguarding data and ensuring smooth operations.
AI Unlocking New Possibilities for Pharma and HCPs
For pharmaceutical companies, AI offers a powerful means to enhance productivity and innovation. It enables a deeper understanding of market trends and customer needs, allowing pharma companies to customize their approaches to different segments more effectively.
With the right AI-powered tools, pharmaceutical and life sciences organizations can bridge gaps in information accessibility, optimize engagement strategies, and streamline internal collaboration. AI-driven platforms enhance precision in HCP engagement by analyzing real-time data, including prescription trends, digital engagement patterns, and sentiment analysis, enabling pharma companies to deliver hyper-personalized, omnichannel interactions that strengthen brand awareness and accelerate adoption.
Additionally, AI-powered digital assistants equip field teams with real-time intelligence, providing instant access to FAQs, clinical trial updates, competitive intelligence, and compliance guidelines while delivering regulatory insights and context-aware recommendations to refine engagement strategies.
Beyond HCP interactions, AI is also transforming sales planning, enabling data-driven territory optimization, smarter incentive alignment, and adaptive engagement models that balance in-person, digital, and hybrid interactions.
Moreover, AI fosters greater cross-functional collaboration by integrating insights across Medical Affairs, R&D, and Commercial teams, breaking down silos to drive innovation and efficiency. By embedding AI-driven intelligence across operations, pharma and life sciences companies can unlock new commercial possibilities, improve decision-making, and ultimately enhance patient outcomes.
Empowering Pharma Sales with Aviso: Meeting Modern Market Demands
At Aviso AI, we excel in providing state-of-the-art AI solutions specifically designed for the pharmaceutical and healthcare sectors. Our platform equips representatives with AI-driven tools for targeted messaging and video communications, enhancing interactions with HCPs and providing insights into engagement metrics and relationship health. Furthermore, our advanced conversation intelligence and Agentic AI workflows ensure optimal engagement across digital platforms.
AI Agents for Pharma Sales: Aviso's AI Agents redefine how life sciences sales teams engage HCPs by driving commercial excellence through intelligent automation and data-driven insights. These AI-powered agents unify fragmented data sources into a single intelligence hub, automate HCP outreach with AI-driven orchestration, and enhance rep productivity by providing real-time insights and decision support. Additionally, they optimize omnichannel engagement using predictive analytics, ensuring that sales teams operate with a single source of truth for informed decision-making, regulatory compliance, and a seamless HCP engagement experience.
Automated Message Generation: Effective deployment of automation and analytics could save between $200 billion to $360 billion in US healthcare costs. Aviso excels in crafting customized and tailored communications. By leveraging AI to understand and adapt to individual HCP preferences, Aviso ensures that every email or message sent is not only well-received but also maximizes the potential for engagement.
Intelligent Recommendations: Our platform offers invaluable insights by providing research updates, clinical guidelines, and detailed product information based on real-time data and predictive analytics. Aviso surfaces Next Best Actions via a system of nudges for reps. In addition to providing a 360 view of interaction and engagement between a Pharma GTM team and HCPs, Aviso recommends Next Best Actions on who, when, where, and how sellers can engage with HCPs and MSLs to drive transactions and deepen relationships.
HCP Data Management: At the core of effective sales strategies is comprehensive data management. Aviso AI aggregates and synthesizes vast amounts of data to create detailed, continuously updated HCP profiles. With our ICP score, know if the HCP fits your Ideal Customer Profile based on intent, activity, and other data signals. This ensures that our clients always have the most relevant and actionable information at their fingertips.
Rep Assistant: Aviso's AI-powered note-taking and real-time coaching help reps stay focused on the most pertinent information during and after client meetings. This not only enhances the quality of interactions but also aids in better follow-up and client relationship management.
Forecasting and Analytics: Our advanced forecasting capabilities and account planning tools allow sales teams to strategize more effectively, aligning their efforts with market dynamics and potential opportunities.
Mobile App: Understanding the need for mobility in today's fast-paced environment, Aviso offers a comprehensive CRM tool accessible via a mobile app. This ensures that sales reps can remain connected and informed no matter where they are, enhancing productivity and responsiveness.
Management AI: For managers, Aviso provides robust tools to monitor the effectiveness of sales reps and ongoing sales campaigns. Our generative AI assistant, MIKI, serves as an additional resource, offering strategic advice and real-time insights to keep sales teams on track and driving towards their goals.
Omnichannel Integration: Aviso AI champions an integrated omnichannel approach that unifies communication across all platforms — from emails to CRM messages. This seamless integration ensures that every piece of data is harmonized and accessible, providing a cohesive and unified customer experience.
Future-Proof Pharma with AI-Driven Success
Pharmaceutical companies today need advanced AI capabilities that provide real-time, data-driven insights to optimize sales, marketing strategies, and customer engagement. Aviso's purpose-built AI platform equips Pharma and Life Sciences teams with the tools to effectively manage a diverse network of people and technologies, enhancing relationships with healthcare professionals (HCPs) and medical science liaisons (MSLs), and delivering a superior customer experience within a unified workspace.
By enabling omnichannel engagement, Aviso ensures consistent and efficient communication across all platforms, enhancing decision-making processes within the life sciences sector. Our platform's advanced predictive analytics leverage real-world data to forecast trends and sales outcomes, allowing your team to make more informed decisions and adapt strategies proactively.
With Aviso, pharmaceutical companies can achieve deeper engagement, build stronger relationships with healthcare professionals, and drive better business outcomes.
Take the next step towards transforming your pharmaceutical engagement strategies with Aviso AI. Contact us today to discover how our tailored AI solutions can bring about significant improvements in your interactions with HCPs and enhance your overall business performance.
